Clinical Trials
2 trialsNCT02955589 2024-09-19
Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)
HUYABIO International, LLC.
Phase 2 Completed
NCT03336632 2018-07-18
Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT
Sichuan University
Phase 2 Unknown